The technical result of the invention is structurally creation of a biotechnical system of common blister pack elements consistently providing the drug substance with excellent ways of delivering a solid therapeutic dose orally or a liquid subtherapeutic dose sublingually.The combination of individual separate delivery routes for solid therapeutic dose orally or a subtherapeutic liquid dose sublingually is a qualitatively new structural pharmacotherapy unit enabling the postadaptation hormesis effect. The advantage of the new drug form is elimination of the pre-systemic metabolism effect in liver with a subtherapeutic dose along with systemic bioavailability enhancement, prevention of drug destruction by chlorobutanol acid in the stomach and by alkaline contents in the intestines, and body resistance improvement.
